Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

H Huang, KSK Leung, T Garg, A Mazzoleni… - Clinical …, 2023 - Wiley Online Library
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein …
被引用次数：1 相关文章

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic

H Huang, KSK Leung, T Garg, A Mazzoleni… - Clinical …, 2023 - search.proquest.com
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low-density lipoprotein …

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic

H Huang, KSK Leung, T Garg, A Mazzoleni… - Clinical … - pubmed.ncbi.nlm.nih.gov
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low-density lipoprotein …

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic

H Huang, KSK Leung, T Garg, A Mazzoleni, GD Miteu… - 2023 - repository.rcsi.com
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low-density lipoprotein …

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic

H Huang, KSK Leung, T Garg… - Clinical …, 2023 - repository.canterbury.ac.uk
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low-density lipoprotein …
[HTML] nih.gov

[HTML][HTML] Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

H Huang, KSK Leung, T Garg, A Mazzoleni… - Clinical …, 2023 - ncbi.nlm.nih.gov
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein …

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

H Huang, KSK Leung, T Garg, A Mazzoleni… - Clinical …, 2023 - kar.kent.ac.uk
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein …

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

H Huang, KSK Leung, T Garg, A Mazzoleni… - Clinical …, 2023 - kar.kent.ac.uk
Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein …